pSE92: pFuGW-G14p-EYFP
(Plasmid
#240462)
-
PurposeA synthetic GAL4 promoter comprising 14 tandem GAL4 binding sites (G14p) regulating EYFP
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 240462 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 |
Backbone
-
Vector backboneFuGw
- Total vector size (bp) 9056
-
Vector typeLentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert nameEYFP
-
Insert Size (bp)705
Gene/Insert 2
-
Gene/Insert nameG14p
-
Insert Size (bp)306
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSE92: pFuGW-G14p-EYFP was a gift from Lior Nissim (Addgene plasmid # 240462 ; http://n2t.net/addgene:240462 ; RRID:Addgene_240462) -
For your References section:
Optimized pipeline and designer cells for synthetic-biology-based high-throughput screening of viral protease inhibitors. Edri S, El-Atawneh S, Ernst T, Elnekave M, Katzman C, Lanton T, Aldar I, Wolk O, Stern N, Goldblum A, Nissim L. Cell Rep Methods. 2025 Aug 5:101139. doi: 10.1016/j.crmeth.2025.101139. 10.1016/j.crmeth.2025.101139 PubMed 40780218